ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $20,265,944 | +23.0% | 128,689 | +17.6% | 0.01% | +25.0% |
| Q3 2022 | $16,482,266 | -48.3% | 109,444 | -43.5% | 0.00% | -50.0% |
| Q2 2022 | $31,862,892 | -35.4% | 193,825 | -12.5% | 0.01% | -27.3% |
| Q1 2022 | $49,331,903 | -5.2% | 221,577 | +1.1% | 0.01% | 0.0% |
| Q4 2021 | $52,026,000 | +11.5% | 219,206 | +9.6% | 0.01% | +10.0% |
| Q3 2021 | $46,672,000 | +39.5% | 199,983 | +23.0% | 0.01% | +42.9% |
| Q2 2021 | $33,451,000 | -5.0% | 162,539 | -5.2% | 0.01% | -12.5% |
| Q1 2021 | $35,227,000 | -11.2% | 171,471 | -7.3% | 0.01% | -11.1% |
| Q4 2020 | $39,657,000 | +18.3% | 184,891 | +0.8% | 0.01% | 0.0% |
| Q3 2020 | $33,524,000 | +0.2% | 183,434 | +1.0% | 0.01% | -10.0% |
| Q2 2020 | $33,470,000 | -12.5% | 181,598 | -4.2% | 0.01% | -28.6% |
| Q1 2020 | $38,231,000 | +2.2% | 189,480 | -5.2% | 0.01% | +40.0% |
| Q4 2019 | $37,402,000 | +16.2% | 199,880 | -0.9% | 0.01% | 0.0% |
| Q3 2019 | $32,201,000 | -36.6% | 201,763 | 0.0% | 0.01% | -37.5% |
| Q2 2019 | $50,826,000 | +17.3% | 201,763 | +11.4% | 0.02% | +14.3% |
| Q1 2019 | $43,331,000 | +4.2% | 181,052 | 0.0% | 0.01% | -6.7% |
| Q4 2018 | $41,575,000 | -18.8% | 181,052 | 0.0% | 0.02% | -11.8% |
| Q3 2018 | $51,192,000 | +2.5% | 181,052 | +6.5% | 0.02% | 0.0% |
| Q2 2018 | $49,936,000 | +9.5% | 170,052 | -5.9% | 0.02% | +6.2% |
| Q1 2018 | $45,599,000 | +8.8% | 180,658 | -6.9% | 0.02% | +6.7% |
| Q4 2017 | $41,895,000 | +40.1% | 193,958 | +20.6% | 0.02% | +36.4% |
| Q3 2017 | $29,901,000 | +48.0% | 160,890 | +37.4% | 0.01% | +37.5% |
| Q2 2017 | $20,201,000 | -4.3% | 117,109 | -15.3% | 0.01% | -11.1% |
| Q1 2017 | $21,114,000 | +16.5% | 138,270 | +12.4% | 0.01% | +12.5% |
| Q4 2016 | $18,127,000 | +49.4% | 123,020 | +22.4% | 0.01% | +33.3% |
| Q3 2016 | $12,131,000 | -1.2% | 100,501 | -7.7% | 0.01% | 0.0% |
| Q2 2016 | $12,277,000 | -5.7% | 108,887 | -13.0% | 0.01% | 0.0% |
| Q1 2016 | $13,025,000 | +1.2% | 125,117 | +9.6% | 0.01% | 0.0% |
| Q4 2015 | $12,870,000 | +3.0% | 114,117 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $12,496,000 | +14.5% | 114,117 | 0.0% | 0.01% | +40.0% |
| Q2 2015 | $10,916,000 | -30.6% | 114,117 | -32.5% | 0.01% | -37.5% |
| Q1 2015 | $15,739,000 | -0.4% | 168,983 | -12.4% | 0.01% | 0.0% |
| Q4 2014 | $15,805,000 | +127.5% | 192,983 | +78.3% | 0.01% | +100.0% |
| Q3 2014 | $6,948,000 | -42.7% | 108,255 | -45.7% | 0.00% | +33.3% |
| Q2 2014 | $12,130,000 | +103.1% | 199,462 | +100.0% | 0.00% | 0.0% |
| Q1 2014 | $5,972,000 | -6.0% | 99,731 | 0.0% | 0.00% | -25.0% |
| Q4 2013 | $6,354,000 | -6.2% | 99,731 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $6,775,000 | +61.3% | 99,731 | +71.2% | 0.00% | +33.3% |
| Q2 2013 | $4,199,000 | +60.6% | 58,270 | +31.4% | 0.00% | +50.0% |
| Q1 2013 | $2,614,000 | -2.5% | 44,335 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $2,682,000 | +13.5% | 44,335 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $2,364,000 | – | 44,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |